Clorox Co (NYSE:CLX) Given Average Rating of “Hold” by Analysts

Shares of Clorox Co (NYSE:CLX) have earned a consensus recommendation of “Hold” from the fourteen analysts that are presently covering the firm, MarketBeat reports. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $153.27.

Several equities analysts recently commented on CLX shares. Morgan Stanley reiterated an “underweight” rating and issued a $134.00 price objective (down previously from $144.00) on shares of Clorox in a research note on Monday, September 30th. JPMorgan Chase & Co. reiterated an “underweight” rating and issued a $137.00 price objective (down previously from $143.00) on shares of Clorox in a research note on Thursday, October 3rd. Royal Bank of Canada upped their price objective on Clorox to $161.00 and gave the company a “sector perform” rating in a research note on Friday, August 2nd. UBS Group dropped their price objective on Clorox from $128.00 to $125.00 and set a “sell” rating on the stock in a research note on Thursday, October 3rd. Finally, Barclays reiterated a “sell” rating on shares of Clorox in a research note on Friday, October 4th.

Shares of NYSE CLX traded down $0.81 during midday trading on Monday, reaching $148.89. The company’s stock had a trading volume of 18,436 shares, compared to its average volume of 1,109,388. Clorox has a 12-month low of $143.58 and a 12-month high of $167.70. The firm has a 50 day moving average price of $154.09 and a 200-day moving average price of $154.98. The stock has a market capitalization of $18.74 billion, a P/E ratio of 23.57, a PEG ratio of 5.04 and a beta of 0.40. The company has a debt-to-equity ratio of 4.09, a current ratio of 0.91 and a quick ratio of 0.55.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, August 1st. The company reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. Clorox had a return on equity of 118.88% and a net margin of 13.20%. The firm had revenue of $1.63 billion for the quarter, compared to the consensus estimate of $1.69 billion. During the same quarter in the previous year, the business earned $1.66 EPS. The company’s revenue was down 3.8% compared to the same quarter last year. On average, equities analysts predict that Clorox will post 6.14 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Wednesday, October 30th will be issued a dividend of $1.06 per share. The ex-dividend date of this dividend is Tuesday, October 29th. This represents a $4.24 dividend on an annualized basis and a yield of 2.85%. Clorox’s payout ratio is 67.09%.

In other Clorox news, SVP Michael R. Costello sold 6,997 shares of the business’s stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $162.56, for a total transaction of $1,137,432.32. Following the sale, the senior vice president now owns 29,016 shares of the company’s stock, valued at approximately $4,716,840.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Diego J. Barral sold 1,987 shares of the business’s stock in a transaction on Friday, August 2nd. The shares were sold at an average price of $157.59, for a total transaction of $313,131.33. The disclosure for this sale can be found here. Insiders have sold a total of 15,609 shares of company stock worth $2,497,443 in the last three months. Insiders own 1.14% of the company’s stock.

A number of hedge funds have recently modified their holdings of the business. Cypress Asset Management Inc. TX increased its holdings in shares of Clorox by 9.5% in the third quarter. Cypress Asset Management Inc. TX now owns 8,155 shares of the company’s stock worth $1,238,000 after purchasing an additional 705 shares during the period. Whittier Trust Co. increased its holdings in shares of Clorox by 3.2% in the third quarter. Whittier Trust Co. now owns 6,155 shares of the company’s stock worth $935,000 after purchasing an additional 193 shares during the period. Stephens Inc. AR increased its holdings in shares of Clorox by 1.4% in the third quarter. Stephens Inc. AR now owns 6,586 shares of the company’s stock worth $1,000,000 after purchasing an additional 89 shares during the period. Bailard Inc. increased its holdings in shares of Clorox by 4.5% in the third quarter. Bailard Inc. now owns 3,481 shares of the company’s stock worth $529,000 after purchasing an additional 150 shares during the period. Finally, Tuttle Tactical Management bought a new position in shares of Clorox in the third quarter worth $1,809,000. 78.45% of the stock is currently owned by institutional investors and hedge funds.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Featured Story: How to find the components of the quick ratio

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.